4th Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$780,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

S. 995, H.R. 2146 Bipartisan Congressional Trade Priorities and Accountability Act, regarding intellectual property rights in trade agreements and international negotiations.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Bills named: S. 995 (114th), H.R. 2146 (114th)

Copyright/Patent/Trademark CPT

HR 9, the Innovation Act, regarding all biopharmaceutical related provisions. S. 1137, Protecting American Talent and Entrepreneurship Act, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 9 (114th), S. 1137 (114th)

Health Issues HCR

Labor, HHS Appropriations,regarding all biopharmaceutical related provisions. Agriculture Appropriations, regarding all biopharmaceutical related provisions. H.R. 1078, FDA Safety Over Sequestration Act, regarding all biopharmaceutical related provisions. No bill, raised awareness about atrial fibrillation and stroke prevention. H/R. 1101, Viral Hepatitis Testing Act, regarding all biopharmaceutical related provisions. H.R.6, 21st Century Cures Initiative and Senate Innovation for a Healthier America proposal, regarding all biopharmaceutical related provisions. No Bill, lobbied Congress on biosimilar issues including naming, labeling and interchangability.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 6 (114th), H.R. 1078 (114th)

Medicare/Medicaid MMM

H.R. 1416, Cancer Patient Protection Act, regarding all biopharmaceutical related provisions. H.R. 1190 and S. 41, Protecting Seniors' Access to Medicare Act, regarding all biopharmaceutical related provisions. H.R. 2, Medicare Access and CHIP Authorization Act, regarding all biopharmaceutical related provisions H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 1190 (114th), H.R. 2 (114th), H.R. 2570 (114th), H.R. 1416 (114th), S. 41 (114th)

Budget/Appropriations BUD

S. Con. Res. 11, budget resolution, regarding all biopharmaceutical related provisions. H.R. 719, Continuing Appropriations Act,regarding all biopharmaceutical related provisions. H.R. 2029, Consolidates Appropriations Act, regarding all biopharmaceutical related provsions. H.R. 3762, Restoring America's Healthcare Freedom Reconciliation Act, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2029 (114th), H.R. 719 (114th), H.R. 3762 (114th), S.Con.Res. 11 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.